Skip Navigation Links

Project Information

USING CER TO IMPROVE ANTIBIOTIC PRESCRIBING AND OUTCOMES IN CHILDREN

Agency:
AHRQ

HHS/Agency for Healthcare Research and Quality

Project Number:
1K08HS023320-01
Contact PI / Project Leader:
HERSH, ADAM L.
Awardee Organization:
UNIVERSITY OF UTAH

Description

Abstract Text:
DESCRIPTION (provided by applicant): The proposed career development award is designed to support the transition of Dr. Adam L. Hersh into an independent physician-scientist using comparative-effectiveness research (CER) methods applied to a patient- centered outcomes research (PCOR) agenda that is dedicated to improving the appropriateness, quality, and safety of antibiotic use of in pediatric care. Dr. Hersh is a pediatric infectious diseases specialist at he University of Utah. The next steps in his career development are to gain advanced skills in quality improvement, epidemiologic, and biostatistical methods for CER and health economics. Dr. Hersh has assembled a mentoring and advisory team with expertise that spans these areas. His AHRQ K08 application proposes 3 research and 4 career development aims that will collectively enable him to become a leader in the areas of antimicrobial stewardship and CER methods in pediatric infectious diseases. Dr. Hersh's application addresses the growing health and economic threat of antibiotic resistance, which is driven in part by the problem of antibiotic overuse. Two important areas of antibiotic overuse include (1) the use of broad-spectrum antibiotics instead of equally effective narrow- spectrum therapy, especially for respiratory infections such as pneumonia; and (2) the use of outpatient parenteral antibiotic therapy (OPAT) instead of equally effective, safer, and less costly oral therapy. The development and implementation of antimicrobial stewardship programs (ASPs) are key strategies to address antibiotic overuse in these areas. However, pediatric ASPs are limited by a weak evidence-base, particularly pertaining to their effectiveness in facilitating guideline uptake and in the comparative-effectiveness of OPAT versus oral therapy for common conditions such as pneumonia, both of which will be strengthened by the proposed research aims. Aim 1 will compare the use of guideline recommended narrow-spectrum antibiotic therapy for pneumonia between hospitals with and without ASPs in a large network of freestanding children's hospitals as a way to assess their effectiveness in facilitating guideline adoption. Aim 2 will compare clinical outcomes between oral therapy and OPAT for children with complicated pneumonia, a condition where treatment practices are highly variable. Finally, Aim 3 will compare the economic burden, including direct and indirect costs and caregiver quality-of-life, between children treated with oral therapy and OPAT in order to provide a better understanding of the economic and caregiver impact of OPAT. In addition to his research aims, Dr. Hersh has proposed four career development aims including coursework and practical experience in the areas of quality improvement; advanced epidemiologic and biostatistical methods for CER; health economics; and leadership. To complete these aims, Dr. Hersh will have access to strong, established resources. The Department of Pediatrics at the University of Utah and Primary Children's Hospital, operated by Intermountain Healthcare, provide ideal environments for the proposed award including a longstanding history and culture of collaborative scientific investigation in the areas of pediatric respiratory infections, quality improvement, implementation science, and CER. The Department of Pediatrics promotes success of early stage investigators by providing resources dedicated to enhancing access to mentorship and grant support services, including a Pediatric Clinical and Translational Research Scholars Program. The University of Utah has outstanding resources dedicated to mentorship, and early career development and training in biostatistical and epidemiologic methods for CER through the NIH-funded Center for Clinical and Translational Science (CCTS) and the Study Design and Biostatistics Center. Intermountain Healthcare offers the Advanced Training Program, a leading training program for physicians in the science of quality improvement. Dr. Hersh currently has 75% protected time which will be ensured throughout the award period to utilize these resources in achieving his career development goals.
Project Terms:
Address; Adoption; Antibiotic Resistance; Antibiotic Therapy; Antibiotics; antimicrobial; Area; Award; Biometry; Biostatistical Methods; career development; Caregivers; Caring; Child; Childhood; Clinical; Communicable Diseases; comparative effectiveness; design; Development; Economic Burden; Economics; Effectiveness; effectiveness research; Ensure; Environment; Epidemiologic Methods; Epidemiology; evidence base; experience; Facilities and Administrative Costs; Funding; Goals; Grant; Guidelines; health economics; Healthcare; Hospitals; implementation science; improved; Investigation; K-Series Research Career Programs; Leadership; Mentors; Mentorship; NCI Scholars Program; Oral; Outcome; Outcomes Research; Outpatients; Patient-Focused Outcomes; pediatric department; Pediatric Hospitals; Physicians; Pneumonia; programs; Quality of life; Recording of previous events; Research; Research Design; Research Methodology; Research Personnel; Resources; Respiratory Tract Infections; Safety; Science; Scientist; Services; skills; Specialist; Staging; success; Time; Training; Training Programs; Translational Research; United States Agency for Healthcare Research and Quality; United States National Institutes of Health; Universities; uptake; Utah

Details

Contact PI / Project Leader Information:
Name:  HERSH, ADAM L.
Other PI Information:
Not Applicable
Awardee Organization:
Name:  UNIVERSITY OF UTAH
City:  SALT LAKE CITY    
Country:  UNITED STATES
Congressional District:
State Code:  UT
District:  02
Other Information:
Fiscal Year: 2014
Award Notice Date: 29-Jul-2014
DUNS Number: 009095365
Project Start Date: 01-Aug-2014
Budget Start Date: 01-Aug-2014
CFDA Code: 226
Project End Date: 31-Jul-2019
Budget End Date: 31-Jul-2015
Agency: ?

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

HHS/Agency for Healthcare Research and Quality
Project Funding Information for 2014:
Year Agency

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

FY Total Cost
2014 AHRQ

HHS/Agency for Healthcare Research and Quality

$160,164

Results

i

It is important to recognize, and consider in any interpretation of Federal RePORTER data, that the publication and patent information cannot be associated with any particular year of a research project. The lag between research being conducted and the availability of its results in a publication or patent award varies substantially. For that reason, it's difficult, if not impossible, to associate a publication or patent with any specific year of the project. Likewise, it is not possible to associate a publication or patent with any particular supplement to a research project or a particular subproject of a multi-project grant.

ABOUT FEDERAL REPORTER RESULTS

Publications: i

Click on the column header to sort the results

PubMed = PubMed PubMed Central = PubMed Central Google Scholar = Google Scholar

Patents: i

Click on the column header to sort the results

Similar Projects

Download Adobe Acrobat Reader:Adobe Acrobat VERSION: 3.41.0 Release Notes
Back to Top